CVA Family Office’s Acadia Pharmaceuticals ACAD Stock Holding History

CVA Family Office’s Portfolio ACAD Stock Details ACAD Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$491	Hold
2025 Q2	$496	Sell
2025 Q1	$831	Hold
2024 Q4	$918	Buy